Literature DB >> 21909952

Interventional therapies of unresectable liver metastases.

Jun Qian1.   

Abstract

Liver metastases are the major cause of mortality in patients with gastrointestinal carcinomas and other malignant tumors, carrying a poor prognosis and presenting considerable management. Surgical resection remains the only curative therapy for liver metastases up to now. However, only a small percentage of patients are suitable for curative resection due to many factors: multi-centric tumors, extrahepatic metastases, early vascular invasion, and coexisting advanced liver cirrhosis. In non-surgical cases, regional interventional therapies have led to a major break through in the treatment of unresectable liver metastases, which include transarterial chemoembolization (TACE), radiofrequency ablation (RFA), laser-induced thermotherapy (LITT), cryosurgical ablation (CSA), microwave coagulation therapy (MCT), percutaneous ethanol injection (PEI), and others. As a result of the technical development of locoregional approaches for unresectable liver metastases during recent decades, the range of combined interventional therapies has been continuously enlarged. The current roles of these treatment options for liver metastases are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909952     DOI: 10.1007/s00432-011-1026-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  73 in total

1.  Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial.

Authors:  P M Sanz-Altamira; L D Spence; M S Huberman; M R Posner; G Steele; L J Perry; K E Stuart
Journal:  Dis Colon Rectum       Date:  1997-07       Impact factor: 4.585

2.  Magnetic resonance imaging--guided abdominal interventional radiology: laser-induced thermotherapy of liver metastases.

Authors:  T J Vogl; M G Mack; R Straub; A Roggan; R Felix
Journal:  Endoscopy       Date:  1997-08       Impact factor: 10.093

3.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

4.  Treatment of colorectal liver metastases by cryotherapy.

Authors:  M L Weaver; J G Ashton; R Zemel
Journal:  Semin Surg Oncol       Date:  1998-03

5.  Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Yasuhiko Nagano; Itaru Endo; Hitoshi Sekido; Shinji Togo
Journal:  Surgery       Date:  2006-02       Impact factor: 3.982

6.  Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma.

Authors:  T Shibata; T Niinobu; N Ogata; M Takami
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

Review 7.  Interventional MR: interstitial therapy.

Authors:  T J Vogl; M G Mack; P K Müller; R Straub; K Engelmann; K Eichler
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

8.  Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer.

Authors:  J K Seifert; D L Morris
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

Review 9.  Cryotherapy for liver tumors: current status, perspectives, clinical results, and review of literature.

Authors:  J K Seifert; T Junginger
Journal:  Technol Cancer Res Treat       Date:  2004-04

10.  [Microwave coagulation therapy for liver metastases from colorectal cancer].

Authors:  Tetsushi Morita; Takashi Shibata; Masaki Okuyama; Kimimasa Ikeda; Yasuo Tsukahara; Masashi Kitada; Miki Nishikubo; Tsuyoshi Ishida; Takashi Shimano
Journal:  Gan To Kagaku Ryoho       Date:  2004-05
View more
  9 in total

Review 1.  Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.

Authors:  Abdul Saied; Steven C Katz; N Joseph Espat
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

2.  Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.

Authors:  Francesco Fiore; Michela Del Prete; Renato Franco; Vincenzo Marotta; Valeria Ramundo; Francesca Marciello; Antonella Di Sarno; Anna Chiara Carratù; Chiara de Luca di Roseto; Annamaria Colao; Antongiulio Faggiano
Journal:  Endocrine       Date:  2014-01-03       Impact factor: 3.633

3.  Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial.

Authors:  Bing Liu; Jian-wen Huang; Yong Li; Bao-shan Hu; Xu He; Wei Zhao; You-bing Zheng; Li-gong Lu
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-14       Impact factor: 4.553

4.  Radiofrequency ablation combined with transarterial chemoembolization for liver metastases from gastrointestinal cancers.

Authors:  Xue-Feng Kan; Yong Wang; Guo-Cheng Lin; Xiang-Wen Xia; Bin Xiong; Guo-Feng Zhou; Hui-Min Liang; Gan-Sheng Feng; Chuan-Sheng Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

5.  Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases.

Authors:  Lihua Chen; Jiuquan Zhang; Lin Zhang; Jing Bao; Chen Liu; Yunbao Xia; Xuequan Huang; Jian Wang
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

6.  High-intensity focused ultrasound provides palliation for liver metastasis causing gastric outlet obstruction: case report.

Authors:  Michele Rossi; Claudio Raspanti; Ernesto Mazza; Ilario Menchi; Angelo Raffaele De Gaudio; Riccardo Naspetti
Journal:  J Ther Ultrasound       Date:  2013-07-01

7.  Image-Guided Radiofrequency Hyperthermia (RFH)-Enhanced Direct Chemotherapy of Hepatic Tumors: The Underlying Biomolecular Mechanisms.

Authors:  Kun Qian; Minjiang Chen; Feng Zhang; Jeffrey Forris Beecham Chick; Hongxiu Ji; Chuansheng Zheng; Xiaoming Yang
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

8.  Percutaneous ethanol injection for liver metastases.

Authors:  Mateusz J Swierz; Dawid Storman; Robert P Riemsma; Robert Wolff; Jerzy W Mitus; Michal Pedziwiatr; Jos Kleijnen; Malgorzata M Bala
Journal:  Cochrane Database Syst Rev       Date:  2020-02-04

9.  Portal Vein Stenting Combined with 125I Particle Chain Implantation Followed by As2O3 in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumour Thrombus.

Authors:  Zhaonan Li; Guangyan Si; De-Chao Jiao; Xinwei Han; Wenguang Zhang; Yahua Li; Xueliang Zhou; Juanfang Liu; Jianjian Chen
Journal:  Biomed Res Int       Date:  2020-01-31       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.